[1]罗 晨,杨嘉恩,梁惠卿.酒精性肝病中西医辨治研究进展[J].医学信息,2018,31(15):16.[doi:10.3969/j.issn.1006-1959.2018.15.008]
 LUO Chen,YANG JIA-en,LIANG HUI-qin.Advances in Differentiation and Treatment of Traditional Chinese and Western Medicine for Alcoholic Hepatitis[J].Journal of Medical Information,2018,31(15):16.[doi:10.3969/j.issn.1006-1959.2018.15.008]
点击复制

酒精性肝病中西医辨治研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年15期
页码:
16
栏目:
综述
出版日期:
2018-08-01

文章信息/Info

Title:
Advances in Differentiation and Treatment of Traditional Chinese and Western Medicine for Alcoholic Hepatitis
文章编号:
1006-1959(2018)15-0016-05
作者:
罗 晨1杨嘉恩2梁惠卿2
1.福建中医药大学第一临床医学院,福建 福州 350122; 2.厦门市中医院,福建 厦门 361001
Author(s):
LUO Chen1YANG JIA-en2LIANG HUI-qin2
1.The First Clinical Medical College,Fujian University of Traditional Chinese Medicine,Fuzhou 350122,Fujian,China; 2.Xiamen Traditional Chinese Medicine Hospital,Xiamen 361001,Fujian,China
关键词:
中西医结合酒精性肝病辨证论治
Keywords:
Key words:Integrated traditional Chinese and western medicineAlcoholic hepatitisSyndrome differentiation and treatment
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2018.15.008
文献标志码:
A
摘要:
酒精性肝病在肝脏疾病中有较高的发生率,早期表现为酒精性脂肪肝症状,随着疾病的进展,可伴随肝纤维化的发生,最终演变为肝硬化、肝衰竭。本文将归纳总结酒精性肝病中西医辨治的研究进展,主要从理、法、治疗等几个方面叙述,通过中西医结合对酒精性肝病的理解和认识,为酒精性肝病的治疗提供理论参考。
Abstract:
Abstract:Alcoholic hepatitis has a high incidence in liver disease,and early manifestations of alcoholic fatty liver disease,with the progress of the disease,can accompany the occurrence of liver fibrosis,and eventually evolve into cirrhosis,liver failure.This article will summarize the research progress of Chinese and western medicine in the treatment of alcoholic hepatitis,mainly from the aspects of theory,method,treatment,etc.,through the understanding of alcoholic hepatitis by integrated traditional Chinese and western medicine,provide a theoretical reference for the treatment of alcoholic hepatitis.

参考文献/References:

[1]周可林,陈绍红.伤酒导致多脏器损伤的中医研究[J].中国社区医师,2016,32(27):14,16.
[2]周新兰,任洪丽.脂肪肝中医病因病机探析[J].辽宁中医药大学学报,2014,16(6):173-175.
[3]曾民德.脂肪肝发病机制及其“二次打击”假设[J].中华消化杂志,2002,22(3):167-168.
[4]张文宇,马满玲.细胞色素P4502E1与乙醇代谢相关的肝损伤研究进展[J].西部医学,2016,28(11):1625-1628.
[5]伍振辉,孟娴,胡佳伟,等.TLR4-MyD88-NF-kB信号通路与肝炎-肝纤维化-肝癌轴相关性研究进展[J].国际药学研究杂志,2017,44(05):396-401.
[6]张子杰,袁征,闫振宇.肝细胞癌组织中TLR4、MyD88、NF-kB表达量及其与临床病理特征的相关性分析[J].中国现代医学杂志,2017,27(04):55-58.
[7]吴圣伟.肠-肝轴在酒精性肝病发生发展中的作用[D].蚌埠医学院,2016.
[8]楼招欢,王军伟.“肠-肝轴”在酒精性肝病中的作用及乌药的干预研究进展[J].浙江中医药大学学报,2017,41(06):545-547.
[9]王全楚,步子恒,李青上.肠肝轴的现代概念及其在肝脏疾病中的作用[J].胃肠病学和肝病学杂志,2015,24(09):1155-1158.
[10]马臻奇,赵彬,郑有花.核因子κB、转化因子β1与酒精性肝病的关系[J].青海医药杂志,2016,46(10):78-80.
[11]Park JK,Shao M,Kim MY,et al.An endoplasmic reticulum protein,Nogo‐B,facilitates alcoholic liver disease through regulation of kupffer cell polarization[J].Hepatology,2017,65(5):1720-1734.
[12]Zhou H,Yu M,Zhao J,et al.IRAKM‐Mincle axis links cell death to inflammation:Pathophysiological implications for chronic alcoholic liver disease[J].Hepatology,2016,64(6):1978-1993.
[13]Wiest R,Albillos A,Trauner M,et al.Targeting the gut-liver axis in liver disease[J].Journal of Hepatology,2017,67(5):1084.
[14]Eguchi A,Lazaro RG,Wang J,et al.Extracelluar vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood[J].Hepatology,2017,65(2):475-490.
[15]Blaya D,Coll M,Rodrigotorres D,et al.Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation[J].Gut,2016,65(9):1535-1545.
[16]Hagstrm H,Stl P,Hultcrantz R,et al.Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study[J].Journal of Hepatology,2016,65(2):363-368.
[17]Andreasson A,Carlsson A C,nnerhag K,et al.Waist Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index:A Population-based Cohort Study[J].Clin Gastroenterol Hepatol,2017,15(8):1294-1301.
[18]严清霜.酒精性肝病中医证素分布规律研究[D].福建中医药大学,2012.
[19]韩相国,鹿守印,罗爱琴,等.超声诊断脂肪肝与酒精肝的临床价值[J].实用医学影像杂志,2017,18(1):88-89.
[20]沈国良,高雅文,王丽萍,等.脂肪肝辨证分型与B超分度间的关系研究[J].浙江中医杂志,2004(03):14-15.
[21]张婷,董淑娟,韩艳俊.脂肪衰减参数在不同中医证型脂肪肝诊断中的应用[J].河南中医,2016,36(11):1940-1942.
[22]姚志山,张会玲,刘丁丁,等.酒精性肝病中医证型与肝功能、血脂的相关性分析[J].中西医结合肝病杂志,2016,26(01):48-50.
[23]黄群,张传涛,刘业方.中医“实脾”理论治疗现代肝病的理论及实践[J].浙江中医药大学学报,2017,41(03):223-225.
[24]邓翠丽.以“治未病”思想为指导的中医健康管理在非酒精性脂肪肝中的应用[D].广州中医药大学,2011.
[25]马成艳.酒精性肝病患者行心理治疗与不行心理治疗的预后戒酒效果比较[J].药物与临床,2015,9(20):409.
[26]田丽艳,陆伦根.2010年美国肝病学会酒精性肝病指南解读[J].中国医学前沿杂志(电子版),2011,3(1):14-16.
[27]黎俊,韩涛.酒精性肝病与营养不良[J].实用肝脏病杂志,2012,15(03):191-193.
[28]汤英.观察中药降酶汤加西医常规护肝治疗慢性脂肪肝、酒精肝的临床疗效[J].中国医药指南,2015,13(23):202-203.
[29]黄敏贤,吴谦,潘竞锵,等.茵陈蒿汤对酒精性诱导脂肪肝大鼠的护肝、抗自由基损伤和降血脂作用[J].海峡药学,2015,27(02):21-24.
[30]盛国光.中医肝病临床辨治思路探析[J].中西医结合肝病杂志,2006(02):65-67.
[31]詹宗颖,孙明瑜.酒精性肝病的中医治疗及研究进展[J].四川中医,2014,32(10):182-186.
[32]沈靖,黄芳芳,王珠美.戒酒互助小组对酒精性肝病患者饮酒行为自我管理的影响[J].世界华人消化杂志,2017,25(10):904-908.
[33]王迎春,孔维宗.酒精性肝病的营养支持[J].实用肝脏病杂志,2014,17(05):456-458.
[34]邬玲玲,竺雪红,李晓燕.酒精性肝病合并酒精戒断综合征的护理[J].护理与康复,2012,11(12):1132-1133.
[35]展玉涛,孙洪强.酒精戒断综合征的治疗[J].中华消化病与影像杂志(电子版),2014,4(3):149-151.
[36]管增淦,刘克喜.右美托咪定超说明书应用进展[J].中国新药与临床杂志,2015,34(01):1-4.
[37]付守芝,吴红勇,杜晓娟,等.纳洛酮辅助治疗重症酒精戒断综合征25例[J].医药导报,2008(11):1340-1342.
[38]谢迎春.酒精戒断综合征误诊肝性脑病1例[J].临床合理用药杂志,2015,8(26):167.
[39]徐静,李平,耿家宝,等.酒精性肝硬化合并戒断综合征误诊1例[J].肝脏,2015,20(10):840.
[40]张岱,王炳元.酒精性肝病常见临床综合征[J].临床肝胆病杂志,2014,30(2):121-123.
[41]何强,徐有青.酒精性肝病相关临床综合征[J].中国临床医生,2014,42(10):9-14.
[42]谢雯,赵红,成军.S-腺苷蛋氨酸临床研究进展[J].世界华人消化杂志,2010,18(33):3553-3558.
[43]双环醇片临床应用专家委员会.双环醇片临床应用专家建议[J].中华实验和临床感染病杂志电子版,2014,8(6):875-879.
[44]刘晨琪,高丽,霍小位,等.诸葛菜种子水提物对急性酒精肝损伤小鼠的保护作用[J].现代食品科技,2017,33(08):7-11,79.
[45]叶文斌,樊亮,王昱,等.黄果槲寄生果实多糖对急性酒精肝损伤小鼠的保护作用[J].安徽农业大学学报,2017,44(02):218-223.
[46]周源,廖兵,王旭睿,等.姜蚬护肝汤对酒精性肝损伤小鼠模型的保护作用及机制研究[J].中国药师,2017,20(06):1042-1045.
[47]张志毕,杨晖,张媛,等.迷迭香提取物对小鼠急性酒精肝模型保护作用研究[J].天然产物研究与开发,2017,29(02):229-234.
[48]Zhu L,Fu R,Liu X,et al.Soyasaponin Bb Protects Rat Hepatocytes from Alcohol-Induced Oxidative Stress by Inducing Heme Oxygenase-1[J].Pharmacognosy Magazine,2016,12(48):302-306.
[49]Mathurin P,Hadengue A,Bataller R.EASL Clinical Practical Guidelines:Management of Alcoholic Liver Disease[J].Journal of Hepatology,2012,57(2):399-420.
[50]Mitchell MC,Friedman LS,Mcclain CJ.Medical Management of Severe Alcoholic Hepatitis:Expert Review from the Clinical Practice Updates Committee of the AGA Institute[J].Clin Gastroenterol Hepatol,2017,15(1):5-12.
[51]Haque TR.Intestinal microbiota in liver disease[J].Best Practice&Research Clinical Gastroenterology,2016,30(1):133-142.
[52]Hotaik S,Seung WK,Meegun H,et al.Microbiota-based treatments in alcoholic liver disease[J].World Journal of Gastroenterology,2016,22(29):6673-6682.
[53]臧月,王生,刘楠,等.肠道菌群失调介导酒精性肝病发生发展的机制研究进展[J].中国药理学通报,2016,32(04):451-455.

相似文献/References:

[1]张君红,李洪梅,井 洁,等.溃疡性结肠炎中西医结合治疗研究[J].医学信息,2018,31(09):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
 ZHANG Jun-hong,LI Hong-mei,JING Jie,et al.Study on the Treatment of Ulcerative Colitis with Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2018,31(15):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
[2]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
 TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Journal of Medical Information,2022,35(15):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[3]陈雪梅,肖 瑶.广州地区西医现代期刊文献研究[J].医学信息,2019,32(03):6.[doi:10.3969/j.issn.1006-1959.2019.03.003]
 CHEN Xue-mei,XIAO Yao.Research on Western Modern Periodicals of Medicine Literature in Guangzhou Area[J].Journal of Medical Information,2019,32(15):6.[doi:10.3969/j.issn.1006-1959.2019.03.003]
[4]刘 浩,黄 娟.中西医结合临床专业外科基本技术培训模式改革研究[J].医学信息,2019,32(03):25.[doi:10.3969/j.issn.1006-1959.2019.03.009]
 LIU Hao,HUANG Juan.Research on the Reform of Basic Technical Training Mode of Clinical Specialty in Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2019,32(15):25.[doi:10.3969/j.issn.1006-1959.2019.03.009]
[5]李 英,欧宁江,孔俊绯.中西医结合治疗变应性结膜炎的临床观察[J].医学信息,2018,31(19):148.[doi:10.3969/j.issn.1006-1959.2018.19.045]
 LI Ying,OU Ning-jiang,KONG Jun-fei.Clinical Observation on Treatment of Allergic Conjunctivitis with Combination of Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2018,31(15):148.[doi:10.3969/j.issn.1006-1959.2018.19.045]
[6]裴金娜,刘 静,梁震峰,等.中西医结合治疗急性前壁ST段抬高型心肌梗死的临床疗效[J].医学信息,2019,32(08):166.[doi:10.3969/j.issn.1006-1959.2019.08.052]
 PEI Jin-na,LIU Jing,LIANG Zhen-feng,et al.Clinical Efficacy of Integrated Traditional Chinese and Western Medicine in the Treatment of Acute Anterior Wall ST-segment Elevation Myocardial Infarction[J].Journal of Medical Information,2019,32(15):166.[doi:10.3969/j.issn.1006-1959.2019.08.052]
[7]姜小娥.中西医结合治疗慢性乙肝的临床观察[J].医学信息,2019,32(10):160.[doi:10.3969/j.issn.1006-1959.2019.10.053]
 JIANG Xiao-e.Clinical Observation on Treatment of Chronic Hepatitis B with Integrative Medicine Therapy[J].Journal of Medical Information,2019,32(15):160.[doi:10.3969/j.issn.1006-1959.2019.10.053]
[8]阮兴秋,莫 鹏.五海瘿瘤丸联合微波消融术治疗乳房良性肿瘤临床研究[J].医学信息,2019,32(11):81.[doi:10.3969/j.issn.1006-1959.2019.11.022]
 RUAN Xing-qiu,MO Peng.Clinical Study on Treatment of Benign Breast Tumors with Wuhai Yingliu Pills Combined with Microwave Ablation[J].Journal of Medical Information,2019,32(15):81.[doi:10.3969/j.issn.1006-1959.2019.11.022]
[9]邓 伟.冠脉无复流的危险因素及治疗[J].医学信息,2021,34(03):43.[doi:10.3969/j.issn.1006-1959.2021.03.013]
 DENG Wei.Risk Factors and Treatment of No-reflow of Coronary Artery[J].Journal of Medical Information,2021,34(15):43.[doi:10.3969/j.issn.1006-1959.2021.03.013]
[10]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
 JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2019,32(15):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]

更新日期/Last Update: 2018-08-01